文献速递头颈外科

I期HPV相关口咽鳞状细胞癌的影像学淋巴结预后因素

Radiographic nodal prognostic factors in stage I HPV-related oropharyngeal squamous cell carcinoma.
PubMed 文献 · Head Neck · 2018-12-15

中央影像学回顾分析233例I期淋巴结阳性(cT1-2N1)接受根治性同步放化疗的p16阳性口咽鳞状细胞癌患者,多因素分析显示低颈淋巴结肿大(HR=6.55,P<.001)和咽后淋巴结肿大(HR=3.36,P=.009)预测无进展生存期更差,两者也预测总生存期更差,其他影像学特征无预后影响。

要点

  • 低颈淋巴结肿大预测无进展生存期更差(HR=6.55,P<.001)。
  • 咽后淋巴结肿大预测无进展生存期更差(HR=3.36,P=.009)。
  • 低颈和咽后淋巴结肿大也预测总生存期更差(HR=6.38,P=.001;HR=3.32,P=.02)。

核心结论

  • 本分析提示,对于伴有低颈淋巴结肿大或咽后淋巴结肿大的I期淋巴结阳性p16阳性口咽鳞状细胞癌患者,应谨慎考虑降强度治疗。

研究设计与样本

  • 中央影像学回顾分析,纳入233例I期淋巴结阳性(cT1-2N1)接受根治性同步放化疗的p16阳性口咽鳞状细胞癌患者。

主要发现

  • 调整年龄、吸烟史和化疗方案后,低颈淋巴结肿大预测无进展生存期更差(HR=6.55;P<.001)。
  • 咽后淋巴结肿大预测无进展生存期更差(HR=3.36;P=.009)。
  • 低颈淋巴结肿大预测总生存期更差(HR=6.38;P=.001)。
  • 咽后淋巴结肿大预测总生存期更差(HR=3.32;P=.02)。
  • 所有其他影像学特征对无进展生存期或总生存期均无预后影响。

关键数值与推荐

  • 低颈淋巴结肿大:无进展生存期HR=6.55(P<.001),总生存期HR=6.38(P=.001)。
  • 咽后淋巴结肿大:无进展生存期HR=3.36(P=.009),总生存期HR=3.32(P=.02)。

临床怎么用

  • 作者认为,对于伴有低颈淋巴结肿大或咽后淋巴结肿大的I期淋巴结阳性p16阳性口咽鳞状细胞癌患者,应谨慎考虑降强度治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The updated AJCC Cancer Staging Manual groups all p16-positive oropharyngeal squamous cell carcinoma (OPSCC) with unilateral nodal involvement within 6 cm into the new clinical N1 classification, consolidating a heterogeneous group of disease with varying radiographic findings. METHODS: A central radiological review was conducted identifying 233 patients with stage I node-positive (cT1-2N1) disease who underwent definitive concurrent chemoradiation. Factors evaluated included lymph node size, low-neck lymphadenopathy, retropharyngeal lymphadenopathy, overt radiographic extracapsular extension, and matted lymphadenopathy. RESULTS: On multivariate analysis adjusted for age, smoking history, and chemotherapy regimen, low-neck lymphadenopathy (hazard ratio (HR) = 6.55; P < .001) and retropharyngeal lymphadenopathy (HR = 3.36; P = .009) predicted for inferior progression-free survival (PFS). low-neck lymphadenopathy (HR = 6.38; P = .001) and retropharyngeal lymphadenopathy (HR = 3.32; P = .02) also predicted for inferior overall survival (OS). All other radiographic characteristics showed no prognostic impact for PFS or OS. CONCLUSIONS: This analysis suggests that caution should be advised against de-intensification efforts among patients with stage I node-positive p16-positive OPSCC with low-neck lymphadenopathy or retropharyngeal lymphadenopathy.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Bhattasali O, Thompson LDR, Schumacher AJ, et al. Radiographic nodal prognostic factors in stage I HPV-related oropharyngeal squamous cell carcinoma. Head Neck. 2018. PMID: 30552839. doi:10.1002/hed.25504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。